Liability Risk and Insurance
Warning on research standards
Thirteen leading medical journals, including
The Lancet
and its equivalents in the US, Canada, Australia, New Zealand, Denmark and the Netherlands, have issued simultaneous warnings
on the status of clinical trials on behalf of pharmaceutical companies.